Skip to main navigation Skip to search Skip to main content

Intensive care admissions and associated severity of influenza b versus a during influenza B vaccine-mismatched seasons

Maya Korem, Efrat Orenbuch-Harroch, Eli Ben-Chetrit, Sarah Israel, Matan J. Cohen, Sigal Sviri, Phillip D. Levin, Michal Mandelboim, Dana G. Wolf

Research output: Contribution to journalArticlepeer-review

Abstract

Patients admitted to hospital with influenza B and A in Jerusalem, Israel, during the 2015-2016 and 2017-2018 influenza seasons demonstrated similar rates of intensive care unit (ICU) admission and associated disease severity. Most (63%) influenza B ICU patients received influenza B-mismatched trivalent vaccine. These findings call into question the equivalence of trivalent and quadrivalent vaccines in preventing severe influenza B.

Original languageEnglish
Pages (from-to)1049-1052
Number of pages4
JournalClinical Infectious Diseases
Volume69
Issue number6
DOIs
StatePublished - 30 Aug 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • influenza B
  • influenza vaccine
  • intensive care admission
  • quadrivalent influenza vaccine
  • trivalent influenza vaccine

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Intensive care admissions and associated severity of influenza b versus a during influenza B vaccine-mismatched seasons'. Together they form a unique fingerprint.

Cite this